
BioNTech has announced that it has reached the next milestone in the establishment of its mRNA vaccine manufacturing capacities in …

GlaxoSmithKline is to invest £130 million in sub-Saharan Africa over the next five years – money which the company says …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

